October 28, 2020 – Olympus (Center Valley, PA) announced the commercial launch of HANAROSTENT Esophagus TTS self-expanding metal stents (SEMS) made by M.I. Tech and distributed exclusively through Olympus in the U.S.
The Through-the-Scope (TTS) esophageal stent, the newest addition to the Olympus self-expanding stent portfolio, helps to achieve luminal patency in a variety of clinical applications and is designed for use in palliative treatment of esophageal stricture and/or trachea-esophageal fistula caused by malignant tumors.
The stent offers a fully covered or partially covered option.
Pre-loaded into the delivery system, the HANAROSTENT Esophagus TTS fits down the working channel of a standard therapeutic gastroscope and is deployed for placement in the esophagus, the company says.. The hook-and-cross nitinol design, unique to HANAROSTENT products, was designed with patient comfort in mind and enables optimal radial and axial force allowing for the flexibility to conform to a patient’s anatomy and precisely target the stricture.
The new 10.5F HANAROSTENT Esophagus TTS allows for accurate and easy esophageal stenting under direct endoscopic visualization, according to Olympus.